Bluejay Stock Based Compensation To Revenue from 2010 to 2024

BJDX Stock  USD 3.84  0.06  1.54%   
Bluejay Diagnostics Stock Based Compensation To Revenue yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation To Revenue will likely drop to 1.39 in 2024. Stock Based Compensation To Revenue is a metric that compares the total value of stock-based compensation granted by Bluejay Diagnostics to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. View All Fundamentals
 
Stock Based Compensation To Revenue  
First Reported
2010-12-31
Previous Quarter
1.56
Current Value
1.39
Quarterly Volatility
0.09818904
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay Diagnostics' main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Interest Expense of 22.8 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0 or PTB Ratio of 24.26. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Bluejay Diagnostics Correlation against competitors.
For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bluejay Stock Analysis

When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.